fropenem has been researched along with Respiratory Tract Infections in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 7 (77.78) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM | 1 |
Abe, T; Azagami, S; Bamba, M; Cho, H; Hojo, H; Jozaki, K; Koizumi, Y; Nakao, A; Nonoyama, M; Ojima, T; Ozaki, A; Sunakawa, K; Yokota, T | 1 |
Blosser-Middleton, RS; Critchley, IA; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C | 1 |
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
Sakata, H | 1 |
Amyes, AK; Amyes, SG; Walsh, F | 1 |
Akita, H; Goshima, T; Ishihara, T; Iwai, N; Iwata, S; Kanemura, H; Kato, T; Kusumoto, Y; Meguro, H; Nakamura, H; Nakashima, M; Satoh, Y; Sunakawa, K; Terashima, I; Toyonaga, Y; Yokota, T | 1 |
Arata, J; Moritono, S; Saito, A | 1 |
Capper, TP; du Plessis, M; Klugman, KP | 1 |
1 trial(s) available for fropenem and Respiratory Tract Infections
Article | Year |
---|---|
[Clinical evaluation of faropenem against infections in pediatric fields].
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Diarrhea; Dosage Forms; Drug Therapy, Combination; Female; Humans; Infant; Lactams; Male; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections | 1997 |
8 other study(ies) available for fropenem and Respiratory Tract Infections
Article | Year |
---|---|
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2007 |
[Efficacy and safety of faropenem in pediatric patients with bacterial infectious diseases].
Topics: beta-Lactams; Child; Child, Preschool; Dosage Forms; Drug Resistance, Bacterial; Humans; Otitis Media; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Treatment Outcome; Urinary Tract Infections | 2008 |
Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Europe; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 2003 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
The in vitro effects of faropenem on lower respiratory tract pathogens isolated in the United Kingdom.
Topics: Anti-Bacterial Agents; beta-Lactams; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 2003 |
[Significant role of penem antibiotics: focused on faropenem (discussion)].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Lactams; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1997 |
In vitro activity of faropenem against respiratory pathogens.
Topics: Anti-Bacterial Agents; beta-Lactams; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 2002 |